Patents by Inventor Asim Kumar Debnath

Asim Kumar Debnath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED HETEROCYCLICS WITH THERAPEUTIC ACTIVITY IN HIV
    Publication number: 20230058961
    Abstract: Substituted heterocyclic substituted pyrrole carboxamide compounds such as those represented by Formula I or Formula II are provided herein. Such compounds, or pharmaceutically acceptable salts thereof, can be used in the treatment of HIV infection and related conditions.
    Type: Application
    Filed: November 19, 2020
    Publication date: February 23, 2023
    Inventors: Asim Kumar DEBNATH, Francesca CURRELI
  • Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
    Patent number: 11571409
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: February 7, 2023
    Assignee: New York Blood Center, Inc.
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • RESPIRATORY VIRUS INHIBITORS
    Publication number: 20220348569
    Abstract: Disclosed herein are compounds which demonstrate activity against respiratory viruses, such as coronaviruses.
    Type: Application
    Filed: December 29, 2021
    Publication date: November 3, 2022
    Inventors: Asim Kumar Debnath, Francesca Curreli, Christopher D. Hillyer, Shahad Ahmed
  • INHIBITORS OF ZIKA VIRUS INFECTION
    Publication number: 20220313651
    Abstract: The present specification provides methods of treatment of flavivirus infection, such as Zika or dengue vims infection, by administration of gossypol, a gossypol derivative, digitonin, or conessine. These compounds may be used alone, in combination with each other, or in combination with curcumin or bortezomib.
    Type: Application
    Filed: August 20, 2020
    Publication date: October 6, 2022
    Inventors: Lanying DU, Asim Kumar DEBNATH, Shibo JIANG, Yaning GAO
  • SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV
    Publication number: 20210340126
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Application
    Filed: July 2, 2021
    Publication date: November 4, 2021
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
    Patent number: 11059808
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Grant
    Filed: August 23, 2016
    Date of Patent: July 13, 2021
    Assignees: New York Blood Center, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV
    Publication number: 20210093608
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Application
    Filed: December 8, 2020
    Publication date: April 1, 2021
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
    Patent number: 10869856
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: December 22, 2020
    Assignees: New York Blood Center, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV
    Publication number: 20200231571
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Application
    Filed: August 23, 2016
    Publication date: July 23, 2020
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV
    Publication number: 20200163935
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Application
    Filed: January 30, 2020
    Publication date: May 28, 2020
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
    Patent number: 10576059
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: March 3, 2020
    Assignees: New York Blood Center, Inc., The United States of America, as Represented by the Secretary, Department of Human Services
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV
    Publication number: 20190343797
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Application
    Filed: July 24, 2019
    Publication date: November 14, 2019
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
    Patent number: 10413527
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: September 17, 2019
    Assignees: New York Blood Center, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV
    Publication number: 20190070146
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Application
    Filed: November 1, 2018
    Publication date: March 7, 2019
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
    Patent number: 10137107
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: November 27, 2018
    Assignees: New York Blood Center, Inc., National Institutes of Health
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • ANTIBODY-DRUG CONJUGATES FOR REDUCING THE LATENT HIV RESERVOIR
    Publication number: 20180028658
    Abstract: Disclosed herein are antibody-drug conjugates having the general formula A-L-D, wherein A represents a neutralizing antibody specific for human immunodeficiency virus (HIV), L represents a linker, and D represents a cytotoxic moiety, pharmaceutical compositions comprising the antibody-drug conjugates, and methods of treating HIV with the antibody-drug conjugates after activation of latent reservoir cells.
    Type: Application
    Filed: February 16, 2016
    Publication date: February 1, 2018
    Inventors: Asim Kumar Debnath, Hongtao Zhang
  • SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV
    Publication number: 20170273943
    Abstract: Substituted phenylpyrrolecarboxamide compounds such as those represented by Formula A can be used in the treatment of HIV infection and related conditions.
    Type: Application
    Filed: September 18, 2015
    Publication date: September 28, 2017
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • HIV inhibitors
    Patent number: 9309237
    Abstract: Chemical compounds that inhibit retroviruses are presented herein. More particularly, this disclosure provides small molecule compounds that inhibit infection with, or treat infection caused by, human immunodeficiency viruses.
    Type: Grant
    Filed: September 6, 2012
    Date of Patent: April 12, 2016
    Assignees: NEW YORK BLOOD CENTER, INC., THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Asim Kumar Debnath, Francesca Curreli, Peter D. Kwong, Young Do Kwon
  • Stabilized therapeutic small helical antiviral peptides
    Patent number: 8940864
    Abstract: Provided are constrained peptides that inhibit HIV assembly. Pharmaceutical compositions comprising the above peptides are also provided. Additionally provided are methods of inhibiting replication of a capsid-containing virus in a cell. Also provided are methods of treating a mammal infected with a capsid-containing virus. Further provided are methods of treating a mammal at risk for infection with a capsid-containing virus. Methods of making the above peptides are additionally provided, as are uses of the above peptides and pharmaceutical compositions.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: January 27, 2015
    Assignee: New York Blood Center, Inc.
    Inventors: Asim Kumar Debnath, Hongtao Zhang, Qian Zhao
  • Stabilized therapeutic small helical antiviral peptides
    Patent number: 8937154
    Abstract: Provided are constrained peptides that inhibit HIV assembly. Pharmaceutical compositions comprising the above peptides are also provided. Additionally provided are methods of inhibiting replication of a capsid-containing virus.
    Type: Grant
    Filed: February 2, 2012
    Date of Patent: January 20, 2015
    Assignee: New York Blood Center, Inc.
    Inventors: Asim Kumar Debnath, Hongtao Zhang, Qian Zhao